pyrazines has been researched along with Proteinuria in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CL; Chang, HW; Chang, LT; Chen, HH; Chen, YL; Chen, YT; Leu, S; Sun, CK; Sung, PH; Tsai, TH; Yang, CC; Yip, HK; Zhen, YY | 1 |
| Liu, G; Liu, L; Wang, SX; Wang, Y; Yao, Y; Zhang, YK | 1 |
| Hobeika, L; Self, SE; Velez, JC | 1 |
| Fuchi, N; Hirasawa, A; Hou, Z; Liu, N; Miyamoto, Y; Ohno, H; Oshida, K; Shi, J; Suzuki, Y; Takei, Y; Tsujimoto, G; Xiao, Y; Yamada, M; Yasue, M | 1 |
| Bilan, VP; Jackson, EK; Tofovic, DS | 1 |
| Cornell, LD; Fidler, ME; Nasr, SH; Qian, Q; Sethi, S | 1 |
| Kyle, RA; Steensma, DP | 1 |
| Auli, MJ; Dadhania, D; Hartono, C; Kapur, S; Leeser, D; Lubetzky, M; Walker, J | 1 |
| Bacovsky, J; Lochman, P; Minarik, J; Pika, T; Scudla, V; Tichy, T; Zadrazil, J | 1 |
| Alexander, MP; Méndez, GP; Nasr, SH; Rennke, HG; Watson, DC | 1 |
| Lin, L; Ni, Q; Wang, B; Wang, X | 1 |
| Locke, FL; Morgan, GJ | 1 |
| Dong, H; Tang, R; Tong, J; Wang, Y; Xu, J | 1 |
| Fu, H; Li, J; Li, QX; Shao, L; Xia, L | 1 |
| Anagnostopoulos, A; Bamias, A; Barmparousi, D; Dimopoulos, MA; Gika, D; Grapsa, I; Kastritis, E; Matsouka, C; Psimenou, E; Roussou, M | 1 |
| Higuchi, C; Nakano, Y; Nihei, H; Nishimura, H; Omata, M; Sanaka, T; Shinobe, M; Sugino, N | 1 |
| Cavaggioni, A; Findlay, JB; Tirindelli, R | 1 |
3 review(s) available for pyrazines and Proteinuria
| Article | Year |
|---|---|
Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cutis Laxa; Dexamethasone; Diabetic Nephropathies; Erythropoietin; Fatal Outcome; Female; Heavy Chain Disease; Hematuria; Humans; Hypertension, Renal; Immunoglobulin alpha-Chains; Immunoglobulin gamma-Chains; Immunoglobulin mu-Chains; Kidney Glomerulus; Male; Multiple Myeloma; Paraproteinemias; Proteinuria; Pyrazines; Thalidomide; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous | 2011 |
Meta-analysis of the clinical effect of ligustrazine on diabetic nephropathy.
Topics: Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Drugs, Chinese Herbal; Humans; Kidney; Ligusticum; Phytotherapy; Proteinuria; Pyrazines | 2012 |
What is the evidence for the use of bisphosphonate therapy in newly diagnosed multiple myeloma patients lacking bone disease?
Topics: Bone Diseases; Boronic Acids; Bortezomib; Dexamethasone; Diphosphonates; Fatigue; Fractures, Bone; Humans; Imidazoles; In Situ Hybridization, Fluorescence; Lenalidomide; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Proteinuria; Pyrazines; Randomized Controlled Trials as Topic; Thalidomide; Time Factors; Translocation, Genetic; Treatment Outcome; Zoledronic Acid | 2012 |
1 trial(s) available for pyrazines and Proteinuria
| Article | Year |
|---|---|
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bence Jones Protein; Boronic Acids; Bortezomib; Dexamethasone; Doxorubicin; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Proteinuria; Pyrazines; Thalidomide; Treatment Outcome; Vincristine | 2007 |
13 other study(ies) available for pyrazines and Proteinuria
| Article | Year |
|---|---|
Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.
Topics: Animals; Biomarkers; Creatinine; Exenatide; Inflammation; Kidney; Male; Oxidative Stress; Peptides; Proteinuria; Pyrazines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Sitagliptin Phosphate; Triazoles; Venoms | 2013 |
Acquired Fanconi syndrome with proximal tubular cytoplasmic fibrillary inclusions of λ light chain restriction.
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Boronic Acids; Bortezomib; Cytoplasm; Dexamethasone; Fanconi Syndrome; Humans; Immunoglobulin Light Chains; Kidney Tubules, Proximal; Male; Microscopy, Fluorescence; Microscopy, Immunoelectron; Multiple Myeloma; Myeloma Proteins; Phagosomes; Proteinuria; Pyrazines; Thalidomide | 2014 |
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
Topics: Acute Kidney Injury; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Edema; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Hypertension, Renal; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Oligopeptides; Podocytes; Proteasome Inhibitors; Proteinuria; Pyrazines; Recurrence; Shock, Septic; Teniposide; Thalidomide; Thrombotic Microangiopathies | 2014 |
The Effects of a Selective CK2 Inhibitor on Anti-glomerular Basement Membrane Glomerulonephritis in Rats.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Casein Kinase II; Creatinine; Emodin; Glomerulonephritis; Kidney Glomerulus; Male; Protein Kinase Inhibitors; Proteinuria; Pyrazines; Rats, Inbred WKY; Testis | 2015 |
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hypertension; Kidney; Male; Metabolic Syndrome; Proteinuria; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sitagliptin Phosphate; Triazoles; Vasoconstriction; Vasoconstrictor Agents | 2010 |
De novo AL amyloidosis in the kidney allograft.
Topics: Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Hematopoietic Stem Cell Transplantation; Humans; Kidney Transplantation; Male; Melphalan; Middle Aged; Prednisone; Proteinuria; Pyrazines; Remission Induction; Treatment Outcome | 2011 |
History of multiple myeloma.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Bence Jones Protein; Boronic Acids; Bortezomib; History, 19th Century; History, Ancient; Humans; Lenalidomide; Melphalan; Multiple Myeloma; Paraproteinemias; Prednisone; Proteinuria; Pyrazines; Stem Cell Transplantation; Thalidomide; Urethane | 2011 |
Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection.
Topics: Adult; Biopsy; Boronic Acids; Bortezomib; Female; Graft Rejection; Graft Survival; HLA Antigens; Humans; Immunity, Humoral; Immunosuppressive Agents; Isoantibodies; Kidney Transplantation; Male; Middle Aged; New York City; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteinuria; Pyrazines; Retrospective Studies; Salvage Therapy; Time Factors; Treatment Outcome | 2010 |
Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement.
Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multiple Myeloma; Prognosis; Proteinuria; Pyrazines; Remission Induction | 2012 |
Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Female; Fluorescent Antibody Technique, Direct; Glomerular Basement Membrane; Glomerulonephritis; Immunoglobulin G; Kidney Glomerulus; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Proteinuria; Pyrazines; Rats; RNA, Messenger; Thromboxane A2 | 2004 |
Protective effect of ligustrazine on accelerated anti-glomerular basement membrane antibody nephritis in rats is based on its antioxidant properties.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Antibodies; Antioxidants; Autoantibodies; Blood Urea Nitrogen; Catalase; Creatinine; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Kidney; Male; Malondialdehyde; Proteinuria; Pyrazines; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase | 2007 |
Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis.
Topics: Animals; Antioxidants; Dipyridamole; Free Radical Scavengers; Immune Complex Diseases; Kidney; Kidney Cortex; Lipid Peroxidation; Male; Malondialdehyde; Nephritis; Phosphatidylcholines; Prednisolone; Proteinuria; Pyrazines; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides | 1997 |
Ligand binding characteristics of homologous rat and mouse urinary proteins and pyrazine-binding protein of calf.
Topics: Animals; Binding, Competitive; Carrier Proteins; Cattle; Crystallization; Lactoglobulins; Ligands; Male; Mice; Odorants; Olfactory Mucosa; Protein Binding; Proteins; Proteinuria; Pyrazines; Rats; Rats, Inbred Strains; Receptors, Odorant | 1990 |